The use of memantine in dementia with Lewy bodies

Marwan N. Sabbagh, Ann Hake, Sahir Ahmed, Martin Farlow

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Objective: To determine the effect of memantine in the treatment of Dementia with Lewy Bodies (DLB). Background: While memantine has been used to successfully treat moderate-to-severe Alzheimer's disease (AD) and some non AD dementias, no reports are available regarding the effect of the drug on DLB. Methods: We reviewed the charts of 11 subjects with DLB by McKeith Criteria that were prospectively evaluated and treated with memantine (with or without cholinesterase inhibitors (ChEIs)) for varying lengths of time. Results: 9 of 11 DLB subjects on memantine were also on ChEIs. Seven of eleven were stable or improved with memantine while the remaining four worsened or responded adversely when exposed to the drug. No adverse effects on motor function were observed. Conclusions: Memantine can be used safely in patients with DLB, but its symptomatic effects may be variable.

Original languageEnglish
Pages (from-to)285-289
Number of pages5
JournalJournal of Alzheimer's Disease
Volume7
Issue number4
StatePublished - 2005

Fingerprint

Memantine
Lewy Body Disease
Alzheimer Disease
Cholinesterase Inhibitors
Pharmaceutical Preparations

Keywords

  • Dementia
  • Lewy bodies
  • Memantine

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology

Cite this

The use of memantine in dementia with Lewy bodies. / Sabbagh, Marwan N.; Hake, Ann; Ahmed, Sahir; Farlow, Martin.

In: Journal of Alzheimer's Disease, Vol. 7, No. 4, 2005, p. 285-289.

Research output: Contribution to journalArticle

Sabbagh, Marwan N. ; Hake, Ann ; Ahmed, Sahir ; Farlow, Martin. / The use of memantine in dementia with Lewy bodies. In: Journal of Alzheimer's Disease. 2005 ; Vol. 7, No. 4. pp. 285-289.
@article{58f6d09d724049cca1cae5fb8ea987d4,
title = "The use of memantine in dementia with Lewy bodies",
abstract = "Objective: To determine the effect of memantine in the treatment of Dementia with Lewy Bodies (DLB). Background: While memantine has been used to successfully treat moderate-to-severe Alzheimer's disease (AD) and some non AD dementias, no reports are available regarding the effect of the drug on DLB. Methods: We reviewed the charts of 11 subjects with DLB by McKeith Criteria that were prospectively evaluated and treated with memantine (with or without cholinesterase inhibitors (ChEIs)) for varying lengths of time. Results: 9 of 11 DLB subjects on memantine were also on ChEIs. Seven of eleven were stable or improved with memantine while the remaining four worsened or responded adversely when exposed to the drug. No adverse effects on motor function were observed. Conclusions: Memantine can be used safely in patients with DLB, but its symptomatic effects may be variable.",
keywords = "Dementia, Lewy bodies, Memantine",
author = "Sabbagh, {Marwan N.} and Ann Hake and Sahir Ahmed and Martin Farlow",
year = "2005",
language = "English",
volume = "7",
pages = "285--289",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - The use of memantine in dementia with Lewy bodies

AU - Sabbagh, Marwan N.

AU - Hake, Ann

AU - Ahmed, Sahir

AU - Farlow, Martin

PY - 2005

Y1 - 2005

N2 - Objective: To determine the effect of memantine in the treatment of Dementia with Lewy Bodies (DLB). Background: While memantine has been used to successfully treat moderate-to-severe Alzheimer's disease (AD) and some non AD dementias, no reports are available regarding the effect of the drug on DLB. Methods: We reviewed the charts of 11 subjects with DLB by McKeith Criteria that were prospectively evaluated and treated with memantine (with or without cholinesterase inhibitors (ChEIs)) for varying lengths of time. Results: 9 of 11 DLB subjects on memantine were also on ChEIs. Seven of eleven were stable or improved with memantine while the remaining four worsened or responded adversely when exposed to the drug. No adverse effects on motor function were observed. Conclusions: Memantine can be used safely in patients with DLB, but its symptomatic effects may be variable.

AB - Objective: To determine the effect of memantine in the treatment of Dementia with Lewy Bodies (DLB). Background: While memantine has been used to successfully treat moderate-to-severe Alzheimer's disease (AD) and some non AD dementias, no reports are available regarding the effect of the drug on DLB. Methods: We reviewed the charts of 11 subjects with DLB by McKeith Criteria that were prospectively evaluated and treated with memantine (with or without cholinesterase inhibitors (ChEIs)) for varying lengths of time. Results: 9 of 11 DLB subjects on memantine were also on ChEIs. Seven of eleven were stable or improved with memantine while the remaining four worsened or responded adversely when exposed to the drug. No adverse effects on motor function were observed. Conclusions: Memantine can be used safely in patients with DLB, but its symptomatic effects may be variable.

KW - Dementia

KW - Lewy bodies

KW - Memantine

UR - http://www.scopus.com/inward/record.url?scp=23944463922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944463922&partnerID=8YFLogxK

M3 - Article

C2 - 16131729

AN - SCOPUS:23944463922

VL - 7

SP - 285

EP - 289

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -